MorphoSys Turns To Loss In Q1; Revenues Fall 81%

German biotechnology company MorphoSys AG (MOR,MPSYY.PK) on Wednesday posted first-quarter net loss of 41.6 million euros or 1.27 euros per share, compared to net income of 195.5 million euros or 6.11 euros per share in the same period last year.

Quarterly revenues dropped 81 percent to 47.2 million euros from 251.2 million euros in the previous-year period.

Looking ahead, the company reaffirmed its revenue guidance of 150 million euros to 200 million euros for fiscal year 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Sturtevant, Wisconsin-based BRP U.S. Inc. is recalling around 20 models of Side-by-Side vehicles citing fire risk, the U.S. Consumer Product Safety Commission. The recall involves about 34,400 units of Model Years 2020 and 2021 Can-AM Defender HD10 side-by-side vehicles. While reporting financial results for the second quarter on Friday, technology company Honeywell international Inc. (HON) raised its adjusted earnings and sales guidance for the full-year 2021, based on the second-quarter performance and management's outlook for the remainder of the year. For fiscal... Shares of Vodafone Group Plc were gaining around 2 percent in the morning trading in London after the British telecom major reported higher revenues in its first quarter. Looking ahead, the company said it is on track to deliver fiscal year 2022 guidance, with Adjusted EBITDAaL expected to be between 15.0 billion euros - 15.4 billion euros and Adjusted free cash flow of at least 5.2 billion euros
Follow RTT